Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Liy-Wong C, Kim M, Kirkorian AY, Eichenfield LF, Diaz LZ, Horev A, Tollefson M, Oranges T, Philips R, Chiu YE, Ghafari G (2021) Hidradenitis suppurativa in the pediatric population: an international, multicenter, retrospective, cross-sectional study of 481 pediatric patients. JAMA Dermatology 157(4):385–391
2. Hu RS, Heffernan J, Sims J, Wojcik MH (2023) Trisomy 13: survival beyond the NICU. Neoreviews 24(1):51–56. https://doi.org/10.1542/neo.24-1-e51PMID: 36587011; PMCID: PMC10184504
3. Goel N, Morris JK, Tucker D, de Walle HE, Bakker MK, Kancherla V, Marengo L, Canfield MA, Kallen K, Lelong N, Camelo JL (2019) Trisomy 13 and 18—Prevalence and mortality—A multi-registry population based analysis. Am J Med Genet Part A 179(12):2382–2392
4. Keyes E, Larijani M, Castelo-Soccio L, Treat JR (2022) Severe recalcitrant hidradenitis suppurativa in a 2‐year‐old boy with partial trisomy 13. Pediatr Dermatol 39(3):491–493
5. Sigg N, Benhard NB, Barbarot S, Martin L (2019) Acneiform lesions associated with trisomy 13. Two cases (poster presentations). Pediatr Dermatol 36(Supplement 1):S48